Dyne Therapeutics, Inc. DYN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$120.85M-7.9% | -$111.96M-3.6% | -$108.04M+2.5% | -$110.86M+3.9% | -$115.36M-28.8% | ||
| $550K+5.6% | $521K+4.2% | $500K0.0% | $500K-0.4% | $502K+11.6% | ||
| $13.08M+16.5% | $11.23M+1.3% | $11.08M+5.3% | $10.52M-19.2% | $13.02M+24.3% | ||
| -$144.92M-29.6% | -$111.83M-23.2% | -$90.78M+4.1% | -$94.7M+10.6% | -$105.89M-25.6% | ||
| $221K-54.3% | $484K+22.5% | $395K+558% | $60K-93.9% | $981K-8.7% | ||
| -$2.39M— | $0+100% | -$37.97M-660% | $6.77M+365% | $1.46M+109% | ||
| —— | $49.45M— | —— | —— | —— | ||
| $7.06M-98.4% | $430.97M+98.3% | $217.33M+116% | $100.77M-28.7% | $141.24M+3,785% | ||
| -$140.25M-144% | $320.12M+261% | $88.58M+590% | $12.85M-65.1% | $36.81M— | ||
| -$145.14M-29.2% | -$112.32M-23.2% | -$91.17M+3.8% | -$94.76M+11.3% | -$106.87M-25.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dyne Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Dyne Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.